Table 1.
Baseline Characteristics
| Characteristic | All Patients (N = 2,840) | Discontinued HHD (n = 729*) |
|---|---|---|
| Age at HHD initiation, years | 52 ± 14.5 | 53 ± 14.5 |
| Race | ||
| White | 1,989 (70.0) | 500 (68.6) |
| Black | 748 (26.3) | 203 (27.9) |
| Other | 103 (3.6) | 26 (3.6) |
| Hispanic Ethnicity | 140 (5.0) | 37 (5.2) |
| Sex | ||
| Female | 964 (33.9) | 259 (35.5) |
| Male | 1,876 (66.1) | 470 (64.5) |
| Primary ESRD cause | ||
| Diabetes | 908 (32.0) | 263 (36.1) |
| Hypertension | 596 (21.0) | 159 (21.8) |
| Glomerulonephritis | 550 (19.4) | 124 (17) |
| Cystic | 185 (6.5) | 36 (4.9) |
| Other | 513 (18.1) | 126 (17.3) |
| Unknown | 86 (3.0) | 21 (2.9) |
| ESRD duration at HHD initiation (years) | 2.1 [0.6–5.6] | 2.2 [0.78–5.3] |
| Median household income ($) | 51,746 [41,083–67,713] | 51,748 [41,109 – 67,651] |
| Current Smoking/Alcohol/Drug use | 189 (6.8) | 58 (8.2) |
| Comorbid Conditions** | ||
| Diabetes | 1,066 (38.4) | 319 (44.8) |
| Inability to ambulate or transfer | 68 (2.5) | 21 (3.0) |
| No. of other comorbid conditions** | ||
| 0 | 312 (11) | 86 (11.8) |
| 1 | 1,628 (57) | 391 (53.6) |
| ≥ 2 | 900 (32) | 252 (34.6) |
| Listed for transplant at HHD initiation | 977 (34.4) | 200 (27.4) |
| Top Five States represented*** | ||
| California | 227 (8) | 49 (6.7) |
| Florida | 208 (7.3) | 46 (6.3) |
| Pennsylvania | 192 (6.8) | 39 (5.4) |
| Illinois | 152 (5.4) | 45 (6.2) |
| Texas | 151 (5.3) | 36 (4.9) |
| Rural residence: RUCA score ≥7 | 300 (10.6) | 64 (8.9) |
Note: Values for categorical variables are given as number (percentage); values for continuous variables, as mean ± standard deviation or median [interquartile range].
**
Other comorbid conditions include hypertension, peripheral vascular disease, heart disease, cerebrovascular disease, congestive heart failure, cancer, and chronic obstructive pulmonary disease
***
Patients resided in 48 states + Washington D.C.
Abbreviations: HHD, home hemodialysis; ESRD, end-stage renal disease; RUCA, rural- urban commuting area
*
Switched modality; not counting discontinuation due to kidney transplantation or death.